Search Tag: vaccine

Pfizer CEO Says Omicron-Targeted Vaccine is Most Likely Outcome

2022 11 Jan

Pfizer Inc Chief Executive Albert Bourla said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March. Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both... Read more

2021 Forbes CIO Summit Series – Episode 1

2021 25 Mar

Find FORBES On Social Media Read more

2021 in Healthcare: Snowballing into Future

2021 15 Feb

Since the start of the COVID-19 pandemic, digitalisation in healthcare has become as important as probably never before. Its upgraded role spans across a multitude of areas, from blockchain applications and smart hospitals to patient data protection and vaccine logistics. An expert provides an overview of the most promising trends and technologies... Read more

Ensuring COVID-19 Vaccine Traceability

2021 15 Feb

A recent paper (Vander Stichele et al. 2020) published in Vaccine highlighted the need for global monitoring of vaccine use (who was inoculated with which vaccine product, where and when) as well as its safety and effectiveness. HealthManagement.org asked the authors about the challenges of implementing such system in practice and possible measures... Read more

Securing Trust In The Global COVID-19 Supply Chain

2021 28 Jan

Find GS1 Ireland on Social Media       Read more

Volume 20 - Issue 10, 2020

2020 30 Nov

Change content default value Read more

Pregnancy, COVID-19, and Hope for a New Vaccine

2020 30 Nov

Key Points  For the past 10 months, COVID-19 has spread rapidly, debilitating communities, plummeting economies, and killing 1.3 million people worldwide. According to the CDC, pregnant women are at higher risk for severe COVID-19 outcomes compared with non-pregnant women. Immunisations are especially important in pregnancy, to ensure... Read more

Game Changer: COVID-19 Vaccine Offers 90% Protection

2020 11 Nov

According to the latest reports, the COVID-19 vaccine developed by Pfizer and BioNTech has been tested on 43,500 people in six countries and shows 90% protection within seven days after the second dose.   The vaccine, which has been tested in participants in the U.S., Germany, Brazil, Argentina, South Africa and Turkey, could be a real game-changer in... Read more

Better Planning of COVID-19 Vaccine Trials

2020 02 Oct

The world is desperate for a reliable vaccine against COVID-19. However, the pressure for such rapid introduction could lead to deployment of a vaccine that may be weakly effective.   In order to avoid this from happening, three issues must be considered when planning COVID-19 vaccine trials. These include proof of vaccine efficacy and worthwhile... Read more

Challenges and Management in Italy and Lessons Learned

2020 19 May

Prof. Maurizio Cecconi is the President-Elect of the European Society of Intensive Care Medicine (ESICM). He is also the Head of Anaesthesia and Intensive Care Department at Istituto Clinico Humanitas and a full professor of Anaesthesia and ICU at the Humanitas University. Prof. Cecconi has worked in different healthcare systems, including the... Read more